Product Information
JULUCA 50-25 MG TABLET is a brand product labeled by ViiV Healthcare Company, priced at $121.7683 per EA under NDC 49702024213. Its NADAC has been published 415 times since Jul 18, 2018.
Strength
50; 25 mg/1; mg/1
Manufacturer
ViiV Healthcare CompanyNDC
49702024213
Classification
Brand
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
DOLUTEGRAVIR SODIUM; RILPIVIRINE HYDROCHLORIDEApproval Type
New Drug (NDA)
FDA Application
NDA210192On Market Since
11/21/2017
Pharmacological Classes
Price Statistics
The NADAC for JULUCA 50-25 MG TABLET has been published 415 times since Jul 18, 2018, and over the history we have for it it has risen 47.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $121.7683 per EA |
|---|---|
| All-time high | $121.9492 (May 13, 2026) |
| All-time low | $82.6656 (Jul 18, 2018) |
| 52-week high | $121.9492 |
| 52-week low | $117.8872 |
| Median price | $100.9419 |
| Average price | $102.1133 |
| Largest weekly change | +5.9% (Jan 10, 2024) |
| Weeks tracked | 415 |
| Tracking since | Jul 18, 2018 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the dolutegravir sodium and rilpivirine hydrochloride market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of JULUCA 50-25 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for JULUCA 50-25 MG TABLET, manufactured by ViiV Healthcare Company, is $121.7683 per EA (NDC 49702024213), effective Jun 24, 2026.
How has the price of JULUCA 50-25 MG TABLET changed over time?
Over the history we have for it, the NADAC for JULUCA 50-25 MG TABLET has risen 47.3%. It has been tracked across 415 weekly CMS publications since Jul 18, 2018.
What are the highest and lowest recorded NADAC prices for JULUCA 50-25 MG TABLET?
Since Jul 18, 2018, the NADAC for JULUCA 50-25 MG TABLET has ranged from a low of $82.6656 (Jul 18, 2018) to a high of $121.9492 (May 13, 2026), with a median of $100.9419 per EA.
Are there cheaper alternatives to JULUCA 50-25 MG TABLET?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of JULUCA 50-25 MG TABLET, so no direct lower-cost alternative is listed.
Who manufactures JULUCA 50-25 MG TABLET?
JULUCA 50-25 MG TABLET (NDC 49702024213) is labeled by ViiV Healthcare Company, and CMS classifies it as a brand product.
Related Drugs
Same classification